Hiller Nicole, Fritz-Wolf Karin, Deponte Marcel, Wende Wolfgang, Zimmermann Herbert, Becker Katja
Interdisciplinary Research Center, Justus-Liebig-University, Heinrich-Buff-Ring 26-32, 35392 Giessen, Germany.
Protein Sci. 2006 Feb;15(2):281-9. doi: 10.1110/ps.051891106. Epub 2005 Dec 29.
Glutathione S-transferase of the malarial parasite Plasmodium falciparum (PfGST) represents a novel class of GST isoenzymes. Since the architecture of the PfGST substrate binding site differs significantly from its human counterparts and there is only this one isoenzyme present in the parasite, PfGST is considered a highly attractive target for antimalarial drug development. Here we report the mechanistic, kinetic, and structural characterization of PfGST as well as its interaction with different ligands. Our data indicate that in solution PfGST is present as a tetramer that dissociates into dimers in the presence of glutathione (GSH). Fluorescence spectroscopy shows that in the presence of GSH GST serves as ligandin for parasitotoxic ferriprotoporphyrin IX with a high- and a low-affinity binding site. This is supported by a clear uncompetitive inhibition type. Site-directed mutagenesis studies demonstrate that neither Cys 86 nor Cys 101 contribute to the peroxidase activity of the enzyme, which is thus performed GSH-dependently at the active site. Tyr 9 is responsible for the deprotonation of GSH and Lys 15, but also Gln 71 are involved in GSH binding. We furthermore report the 2.4 A resolution X-ray structure of PfGST cocrystallized with the inhibitor S-hexylglutathione. In comparison with a previously reported structure obtained by crystal soaking, differences occur at the C-terminal end of helix alpha4 and at the S-hexylmoiety of the inhibitor. We furthermore show that, in contrast to previous reports, the antimalarial drug artemisinin is not metabolized by PfGST.
恶性疟原虫的谷胱甘肽S-转移酶(PfGST)代表了一类新型的GST同工酶。由于PfGST底物结合位点的结构与其人类对应物有显著差异,且该寄生虫中仅存在这一种同工酶,PfGST被认为是抗疟药物开发的极具吸引力的靶点。在此,我们报告了PfGST的机制、动力学和结构特征以及它与不同配体的相互作用。我们的数据表明,在溶液中PfGST以四聚体形式存在,在谷胱甘肽(GSH)存在下会解离成二聚体。荧光光谱显示,在GSH存在下,GST作为寄生虫毒性铁原卟啉IX的配体蛋白,具有一个高亲和力和一个低亲和力结合位点。这得到了明显的非竞争性抑制类型的支持。定点诱变研究表明,Cys 86和Cys 101均对该酶的过氧化物酶活性无贡献,因此该活性在活性位点上依赖GSH进行。Tyr 9负责GSH的去质子化,Lys 15以及Gln 71也参与GSH结合。我们还报告了与抑制剂S-己基谷胱甘肽共结晶的PfGST的2.4埃分辨率X射线结构。与先前通过晶体浸泡获得的结构相比,在α4螺旋的C末端和抑制剂的S-己基部分出现了差异。我们还表明,与先前的报道相反,抗疟药物青蒿素不会被PfGST代谢。